A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

Michael A. Morse, Jennifer Garst, Takuya Osada, +10

Journal of Translational Medicine

The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients

Takuya Osada, Gabriel T. Chong, Robert Tansik, +9

Cancer Immunology Immunotherapy

Hematological MalignancyMedicineMalignant Blood DisorderImmunologyAnti-vegf Therapy +9

Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines

Michael A. Morse, Amy Hobeika, Takuya Osada, +4

Blood

Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC Mutations

Takuya Osada, Minyong Chen, Xiao Yang, +8

Cancer Research

ImmunologyPathologyCrc CellsCancer BiologyAdenomatous Polyposis Coli +16

Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer

Shigeru Tomozawa, Nelson H. Tsuno, Eiji Sunami, +7

British Journal of Cancer

Increasing vaccine potency through exosome antigen targeting

Zachary C. Hartman, Jun-Ping Wei, Oliver Glass, +10

Vaccine

VaccinationMucosal VaccinationCross-protectionVaccine PotencyImmunology +4

CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer

Xinhui Wang, Takuya Osada, Yangyang Wang, +12

JNCI Journal of the National Cancer Institute

An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models

Wenle Xia, Emanual Petricoin, Sumin Zhao, +10

Breast Cancer Research

Phase I Study Utilizing a Novel Antigen-Presenting Cell–Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients

Michael A. Morse, Robert Chapman, John D. Powderly, +14

Clinical Cancer Research

A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer

Michael A. Morse, Donna Niedzwiecki, John L. Marshall, +17

Annals of Surgery